Early Neonatal Glutaric Aciduria Type I Hidden by Perinatal Asphyxia: a Case Report

Overview

Journal Ital J Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2018 Jan 17

PMID 29335023

Citations 1

Authors

Giacomo Biasucci

Nicola Morelli

Federica Natacci

Massimo Mastrangelo

Affiliations

Soon will be listed here.

Abstract

Background: Perinatal asphyxia (PA) occurs in about 2 to 10 per 1000 live full-term births. Although neonatal epileptic seizures are observed in up to 60% of cases, PA may mimic or subtend other conditions. Hypoxia related brain injury is particularly relevant, as it may have permanent effects on neuropsychomotor development. Antepartum obstetric conditions, may, in turn, lead to hypoxic-ischemic damage to the fetus and the newborn, often underlying PA. Herein, a case of PA that hid and triggered signs and symptoms of Glutaric Aciduria type I (GA-I), is reported.

Case Presentation: R.F. was born at term after prolonged labour, by induced vaginal delivery with the Kristeller manoeuvre. He presented with severe asphyxia and asystoly. Immediate cardiopulmonary resuscitation promptly restored cardiorespiratory parameters, allowing for early extubation 30 min after. During the following hours, severe axial muscle hypotonia with an increased tone of the limb extensor muscles became evident. The absence of crying and archaic reflexes persisted and there was an onset of generalized tonic or clonic seizure. First level metabolic and inflammatory markers were within the normal range. An inherited metabolic disease was then suspected, due to the persistent clinical signs of severe neurological damage without any detectable septic parameter. GA-I was assessed and specific treatment started without any clinical improvement, although ensuring adequate growth and metabolic control. Thereafter, the baby developed a severe encephalopathy with drug resistant epileptic seizures. The progression of the neurological damage and a CVC-related sepsis led him to exitus at 2 years.

Conclusions: To the best of our knowledge, this is the first case of early post-natal onset of GA-I reported in literature to date, in the absence of expanded newborn screening (NBS) programme. As expanded NBS programmes for inborn errors of metabolism have not yet been internationally adopted, we are of the opinion that such diseases may well be hidden by misleading signs and symptoms imputable to other more frequent harmful clinical conditions. Moreover, it would be advisable that neonatologists be trained to include GA-I in the differential diagnosis of neurological damage secondary to PA.

Citing Articles

Glutaric Aciduria Type 1: A Case Report and Review of Literature.

Sanju S, Tullu M, Seshadri N, Agrawal M J Pediatr Intensive Care. 2021; 10(1):65-70.

PMID: 33585064 PMC: 7870340. DOI: 10.1055/s-0040-1709704.

References

Harting I, Neumaier-Probst E, Seitz A, Maier E, Assmann B, Baric I . Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain. 2009; 132(Pt 7):1764-82. DOI: 10.1093/brain/awp112. View

Viau K, Ernst S, Vanzo R, Botto L, Pasquali M, Longo N . Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab. 2012; 106(4):430-8. DOI: 10.1016/j.ymgme.2012.05.024. View

Kolker S, Garbade S, Boy N, Maier E, Meissner T, Muhlhausen C . Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res. 2007; 62(3):357-63. DOI: 10.1203/PDR.0b013e318137a124. View

Kolker S, Boy S, Heringer J, Muller E, Maier E, Ensenauer R . Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience. Mol Genet Metab. 2012; 107(1-2):72-80. DOI: 10.1016/j.ymgme.2012.03.021. View

Bjugstad K, Goodman S, Freed C . Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J Pediatr. 2000; 137(5):681-6. DOI: 10.1067/mpd.2000.108954. View

Kolker S, Garbade S, Greenberg C, Leonard J, Saudubray J, Ribes A . Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res. 2006; 59(6):840-7. DOI: 10.1203/01.pdr.0000219387.79887.86. View

Zschocke J, Quak E, Guldberg P, Hoffmann G . Mutation analysis in glutaric aciduria type I. J Med Genet. 2000; 37(3):177-81. PMC: 1734541. DOI: 10.1136/jmg.37.3.177. View

Burlina A, Zara G, Hoffmann G, Zschocke J, Burlina A . Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options. J Inherit Metab Dis. 2004; 27(6):911-5. DOI: 10.1023/B:BOLI.0000045776.50573.52. View

Kolker S, Christensen E, Leonard J, Greenberg C, Boneh A, Burlina A . Diagnosis and management of glutaric aciduria type I--revised recommendations. J Inherit Metab Dis. 2011; 34(3):677-94. PMC: 3109243. DOI: 10.1007/s10545-011-9289-5. View

10.

Boy N, Muhlhausen C, Maier E, Heringer J, Assmann B, Burgard P . Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2016; 40(1):75-101. DOI: 10.1007/s10545-016-9999-9. View

11.

Desai N, Runge V, Crisp D, Crisp M, Naul L . Magnetic resonance imaging of the brain in glutaric acidemia type I: a review of the literature and a report of four new cases with attention to the basal ganglia and imaging technique. Invest Radiol. 2003; 38(8):489-96. DOI: 10.1097/01.rli.0000080405.62988.f6. View

12.

Boy N, Haege G, Heringer J, Assmann B, Muhlhausen C, Ensenauer R . Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters. J Inherit Metab Dis. 2012; 36(3):525-33. DOI: 10.1007/s10545-012-9517-7. View

13.

Chalmers R, Bain M, Zschocke J . Riboflavin-responsive glutaryl CoA dehydrogenase deficiency. Mol Genet Metab. 2005; 88(1):29-37. DOI: 10.1016/j.ymgme.2005.11.007. View

14.

Kolker S, Garcia-Cazorla A, Cazorla A, Valayannopoulos V, Lund A, Burlina A . The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015; 38(6):1041-57. DOI: 10.1007/s10545-015-9839-3. View

15.

Hoffmann G, Athanassopoulos S, Burlina A, Duran M, De Klerk J, Lehnert W . Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 1996; 27(3):115-23. DOI: 10.1055/s-2007-973761. View

16.

Couce M, Lopez-Suarez O, Boveda M, Castineiras D, Cocho J, Garcia-Villoria J . Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol. 2013; 17(4):383-9. DOI: 10.1016/j.ejpn.2013.01.003. View

17.

Pfeil J, Listl S, Hoffmann G, Kolker S, Lindner M, Burgard P . Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis. 2013; 8:167. PMC: 4015693. DOI: 10.1186/1750-1172-8-167. View

18.

Afroze B, Yunus Z . Glutaric aciduria type 1--importance of early diagnosis and treatment. J Pak Med Assoc. 2014; 64(5):593-5. View

19.

Mohammad S, Abdelkhalek H, Ahmed K, Zaki O . Glutaric aciduria type 1: neuroimaging features with clinical correlation. Pediatr Radiol. 2015; 45(11):1696-705. DOI: 10.1007/s00247-015-3395-8. View

20.

Christensen E . Improved assay of glutaryl-CoA dehydrogenase in cultured cells and liver: application to glutaric aciduria type I. Clin Chim Acta. 1983; 129(1):91-7. DOI: 10.1016/0009-8981(83)90155-9. View